注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Aspira Women's Health Inc致力于发现、开发和利用检测选项和生物分析解决方案。其产品包括OVA1和Ovra、OVA1plus、Aspira GenetiX和Aspira Synergy。OVA1是一种血液检测产品,旨在当医生进行独立临床试验计划对其进行手术时帮助进一步评估卵巢附件肿块女性患恶性肿瘤的可能性,Ovra旨在保持OVA1的高度敏感性。OVA1plus是对处于中等风险范围的OVA1测试结果进行的反射测试。Aspira GenetiX是一种针对妇科癌症风险的基因测试,重点关注女性生殖癌症,包括乳腺癌、卵巢癌、子宫内膜癌、子宫癌和宫颈癌。Aspira Synergy是一个基于云技术的成套技术转让解决方案,为临床实验室提供从样本采集到定制白标签报告的端到端解决方案,以实现其产品的内部测试。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Celeste R. Fralick | 63 | 2022 | Independent Director |
Jannie Herchuck | - | 2023 | Independent Director |
Daniel W. Chan | - | 2006 | Member of Scientific Advisory Board |
Jannie P. Herchuk | 60 | 2023 | Independent Chair of the Board |
Tamika Sea | - | 2023 | Member of Clinical Advisory Board |
Winfred Parnell | - | 2023 | Independent Director |
Stefanie L. Cavanaugh | 59 | 2023 | Independent Director |
Nisha Garg | - | 2023 | Member of Clinical Advisory Board |
Levi S. Downs | - | 2023 | Member of Clinical Advisory Board |
Nicole Sandford | 53 | 2021 | CEO & Director |
Farr R. Nezhat | - | - | Member of Scientific Advisory Board |
Donald G. Munroe | 67 | 2011 | Member of Scientific Advisory Board |
Robert E. Bristow | - | - | Member of Scientific Advisory Board |
Judith K. Wolf | - | 2014 | Member of Scientific Advisory Board |
Calaneet Balas | - | - | Member of Scientific Advisory Board |
Ellen O’Connor Vos | 68 | 2023 | Independent Director |
Leo Twiggs | - | 2023 | Chairman of Clinical Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核